| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 2194069 |
|---|
| Description | Potent human fatty acid synthase (hFASN) inhibitor (IC50 = 7.7 nM); inhibits hFAS β-ketoacyl reductase activity. Inhibits lipid synthesis and attenuates proliferation of A549 non-small-cell lung cancer cells (EC50 = 15 nM) in vitro. Purity 99%. MW (observed): 428.48 |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[4-(5-Benzofuranyl)phenyl]-5-[[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one |
|---|
| Gene, Accession, CAS # | CAS: 1332331-08-4 |
|---|
| Catalog # | 5303/25 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2194069 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|